FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912676966> ?p ?o ?g. }

• W2912676966 endingPage "65" @default.
• W2912676966 startingPage "61" @default.
• W2912676966 abstract "The CDC recommended outpatient treatment of pelvic inflammatory disease (PID) is an intramuscular dose of ceftriaxone plus 14 days of doxycycline, with or without metronidazole. European guidelines (2017) include moxifloxacin plus ceftriaxone as a first line regimen, particularly for women with Mycoplasma genitalium-associated PID. However, the susceptibility of bacteria recovered from the endometrium of women with PID to moxifloxacin is unknown. The in vitro antibiotic susceptibility of facultative and anaerobic bacteria recovered from endometrial biopsy samples were evaluated from 105 women having symptomatic PID and/or histologically confirmed endometritis. A total of 342 endometrial isolates from enrollment visits were identified using a combination of biochemical tests and sequencing. Isolates were tested for antimicrobial susceptibility using agar dilution against ceftriaxone, clindamycin, doxycycline, metronidazole and moxifloxacin according to the Clinical and Laboratory Standards Institute (CLSI) guidelines. Neisseria gonorrhoeae was susceptible to ceftriaxone with all isolates having an MIC of 0.03 μg/mL. All the other endometrial isolates were susceptible to ceftriaxone, except for Prevotella species, only half of which were susceptible. The in vitro susceptibility profile for BV-associated bacteria (Gardnerella vaginalis, Atopobium vaginae, Prevotella species, Porphyromonas species and anaerobic gram-positive cocci) revealed greater susceptibility to moxifloxacin compared to doxycycline. Moxifloxacin was superior to metronidazole for G. vaginalis and A. vaginae, and either metronidazole or moxifloxacin was needed to cover Prevotella species. Based on in vitro susceptibility testing, the combination of ceftriaxone plus moxifloxacin provides similar coverage of facultative and anaerobic pathogens compared to the combination of ceftriaxone, metronidazole and doxycycline. Head to head clinical studies of these treatment regimens are needed to evaluate clinical efficacy and eradication of endometrial pathogens following treatment." @default.
• W2912676966 created "2019-02-21" @default.
• W2912676966 creator A5017547539 @default.
• W2912676966 creator A5040572230 @default.
• W2912676966 creator A5040574411 @default.
• W2912676966 creator A5080901034 @default.
• W2912676966 creator A5083764812 @default.
• W2912676966 date "2019-04-01" @default.
• W2912676966 modified "2023-10-02" @default.
• W2912676966 title "Susceptibility of endometrial isolates recovered from women with clinical pelvic inflammatory disease or histological endometritis to antimicrobial agents" @default.
• W2912676966 cites W1832604395 @default.
• W2912676966 cites W1988540010 @default.
• W2912676966 cites W1991821809 @default.
• W2912676966 cites W2006370776 @default.
• W2912676966 cites W2010549257 @default.
• W2912676966 cites W2046161874 @default.
• W2912676966 cites W2049559774 @default.
• W2912676966 cites W2067831653 @default.
• W2912676966 cites W2089206154 @default.
• W2912676966 cites W2102042608 @default.
• W2912676966 cites W2125342917 @default.
• W2912676966 cites W2136422754 @default.
• W2912676966 cites W2137776258 @default.
• W2912676966 cites W2140989045 @default.
• W2912676966 cites W2141231119 @default.
• W2912676966 cites W2153940164 @default.
• W2912676966 cites W2162847806 @default.
• W2912676966 cites W2165122496 @default.
• W2912676966 cites W2269227466 @default.
• W2912676966 cites W2530870781 @default.
• W2912676966 cites W2581386025 @default.
• W2912676966 cites W2615016596 @default.
• W2912676966 cites W2792039994 @default.
• W2912676966 cites W4245249007 @default.
• W2912676966 doi "https://doi.org/10.1016/j.anaerobe.2019.02.005" @default.
• W2912676966 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6559736" @default.
• W2912676966 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30753898" @default.
• W2912676966 hasPublicationYear "2019" @default.
• W2912676966 type Work @default.
• W2912676966 sameAs 2912676966 @default.
• W2912676966 citedByCount "19" @default.
• W2912676966 countsByYear W29126769662019 @default.
• W2912676966 countsByYear W29126769662020 @default.
• W2912676966 countsByYear W29126769662021 @default.
• W2912676966 countsByYear W29126769662022 @default.
• W2912676966 countsByYear W29126769662023 @default.
• W2912676966 crossrefType "journal-article" @default.
• W2912676966 hasAuthorship W2912676966A5017547539 @default.
• W2912676966 hasAuthorship W2912676966A5040572230 @default.
• W2912676966 hasAuthorship W2912676966A5040574411 @default.
• W2912676966 hasAuthorship W2912676966A5080901034 @default.
• W2912676966 hasAuthorship W2912676966A5083764812 @default.
• W2912676966 hasBestOaLocation W29126769661 @default.
• W2912676966 hasConcept C126322002 @default.
• W2912676966 hasConcept C2775846227 @default.
• W2912676966 hasConcept C2776520383 @default.
• W2912676966 hasConcept C2777396551 @default.
• W2912676966 hasConcept C2778836808 @default.
• W2912676966 hasConcept C2779234561 @default.
• W2912676966 hasConcept C2779952448 @default.
• W2912676966 hasConcept C2780018483 @default.
• W2912676966 hasConcept C29456083 @default.
• W2912676966 hasConcept C2992397963 @default.
• W2912676966 hasConcept C2993569511 @default.
• W2912676966 hasConcept C501593827 @default.
• W2912676966 hasConcept C523546767 @default.
• W2912676966 hasConcept C54355233 @default.
• W2912676966 hasConcept C71924100 @default.
• W2912676966 hasConcept C86803240 @default.
• W2912676966 hasConcept C89423630 @default.
• W2912676966 hasConceptScore W2912676966C126322002 @default.
• W2912676966 hasConceptScore W2912676966C2775846227 @default.
• W2912676966 hasConceptScore W2912676966C2776520383 @default.
• W2912676966 hasConceptScore W2912676966C2777396551 @default.
• W2912676966 hasConceptScore W2912676966C2778836808 @default.
• W2912676966 hasConceptScore W2912676966C2779234561 @default.
• W2912676966 hasConceptScore W2912676966C2779952448 @default.
• W2912676966 hasConceptScore W2912676966C2780018483 @default.
• W2912676966 hasConceptScore W2912676966C29456083 @default.
• W2912676966 hasConceptScore W2912676966C2992397963 @default.
• W2912676966 hasConceptScore W2912676966C2993569511 @default.
• W2912676966 hasConceptScore W2912676966C501593827 @default.
• W2912676966 hasConceptScore W2912676966C523546767 @default.
• W2912676966 hasConceptScore W2912676966C54355233 @default.
• W2912676966 hasConceptScore W2912676966C71924100 @default.
• W2912676966 hasConceptScore W2912676966C86803240 @default.
• W2912676966 hasConceptScore W2912676966C89423630 @default.
• W2912676966 hasFunder F4320332161 @default.
• W2912676966 hasLocation W29126769661 @default.
• W2912676966 hasLocation W29126769662 @default.
• W2912676966 hasLocation W29126769663 @default.
• W2912676966 hasLocation W29126769664 @default.
• W2912676966 hasOpenAccess W2912676966 @default.
• W2912676966 hasPrimaryLocation W29126769661 @default.
• W2912676966 hasRelatedWork W13803921 @default.
• W2912676966 hasRelatedWork W1998414444 @default.
• W2912676966 hasRelatedWork W2099151165 @default.
• W2912676966 hasRelatedWork W2137095286 @default.

• next